Drugs / Kera Sol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07155070 Comparator | Aug 2025 → Dec 2026 expected | dry eye syndrome | Vance Thompson Vision | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kera Sol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07155070 ↗ |